IL109685A - History of quinoline Process for their preparation and pharmaceutical preparations for the prevention of secretion of gastric juices containing them - Google Patents
History of quinoline Process for their preparation and pharmaceutical preparations for the prevention of secretion of gastric juices containing themInfo
- Publication number
- IL109685A IL109685A IL10968594A IL10968594A IL109685A IL 109685 A IL109685 A IL 109685A IL 10968594 A IL10968594 A IL 10968594A IL 10968594 A IL10968594 A IL 10968594A IL 109685 A IL109685 A IL 109685A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- quinoline
- mmol
- methylene chloride
- butyryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9302005A SE9302005D0 (sv) | 1993-06-11 | 1993-06-11 | New active compounds |
SE9303970A SE9303970D0 (sv) | 1993-11-30 | 1993-11-30 | New active compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
IL109685A0 IL109685A0 (en) | 1994-11-28 |
IL109685A true IL109685A (en) | 1999-03-12 |
Family
ID=26661770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10968594A IL109685A (en) | 1993-06-11 | 1994-05-19 | History of quinoline Process for their preparation and pharmaceutical preparations for the prevention of secretion of gastric juices containing them |
Country Status (25)
Country | Link |
---|---|
US (1) | US5889021A (es) |
EP (1) | EP0702672B1 (es) |
JP (1) | JP3623794B2 (es) |
CN (1) | CN1045955C (es) |
AT (1) | ATE196134T1 (es) |
AU (1) | AU680516B2 (es) |
BR (1) | BR9406772A (es) |
CA (1) | CA2164875A1 (es) |
CZ (1) | CZ326095A3 (es) |
DE (1) | DE69425823T2 (es) |
EE (1) | EE03123B1 (es) |
EG (1) | EG20435A (es) |
ES (1) | ES2150494T3 (es) |
FI (1) | FI955896A (es) |
HU (1) | HUT75122A (es) |
IL (1) | IL109685A (es) |
IS (1) | IS4164A (es) |
NO (1) | NO305799B1 (es) |
NZ (1) | NZ267740A (es) |
PL (1) | PL177766B1 (es) |
RU (1) | RU2142454C1 (es) |
SG (1) | SG47820A1 (es) |
SK (1) | SK154995A3 (es) |
TW (1) | TW261613B (es) |
WO (1) | WO1994029274A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
US6077850A (en) * | 1997-04-21 | 2000-06-20 | G.D. Searle & Co. | Substituted benzopyran analogs for the treatment of inflammation |
AU2002950217A0 (en) | 2002-07-16 | 2002-09-12 | Prana Biotechnology Limited | 8- Hydroxy Quinoline Derivatives |
ES2877799T3 (es) * | 2015-12-31 | 2021-11-17 | Shanghai Pharmaceuticals Holding Co Ltd | Sal de derivado de quinolina, formas polimórficas de la misma, métodos de preparación de la misma, composición y aplicaciones |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US509804A (en) * | 1893-11-28 | Hoof-weight | ||
US3470186A (en) * | 1967-06-02 | 1969-09-30 | American Cyanamid Co | Substituted 4-anilino-3-quinolinecarboxylic acids and esters |
US4042702A (en) * | 1973-08-16 | 1977-08-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Halogen pyrazole derivatives, a method for producing these halogen pyrazole derivatives, medicaments containing and methods of using them |
LU69428A1 (es) * | 1974-02-20 | 1975-12-09 | ||
US4120972A (en) * | 1975-02-03 | 1978-10-17 | Smith Kline & French Laboratories Limited | Imidazolylmethylthio-ethyl isothiourea compounds |
GB1507957A (en) * | 1975-03-25 | 1978-04-19 | Byk Gulden Lomberg Chem Fab | Nitrofuryl-pyrazole derivatives methods for producing them and medicaments comprising them |
GB1584378A (en) * | 1976-10-14 | 1981-02-11 | Byk Gulden Lomberg Chem Fab | (pyrazol-1-yl)-phenylacetic acids processes for their preparation and medicaments containing them |
LU78804A1 (de) * | 1977-12-30 | 1979-07-20 | Byk Gulden Lomberg Chem Fab | N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
US4243678A (en) * | 1977-12-30 | 1981-01-06 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Acylhydrocarbylaminoalkanoic acids, compositions and uses |
YU118379A (en) * | 1978-05-24 | 1983-02-28 | Byk Gulden Lomberg Chemischefa | Process for preparing phenylaminothiophene acetic acid |
US4343804A (en) * | 1979-03-26 | 1982-08-10 | A. H. Robins Company, Inc. | 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds |
FI68835C (fi) * | 1979-08-03 | 1985-11-11 | Byk Gulden Lomberg Chem Fab | Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-minoacyl-1,4,9,10-tetrahydropyrazolo(4,3-b)(1,5)bensodiaz epn-10-oner |
EP0024638A1 (en) * | 1979-08-30 | 1981-03-11 | Byk Gulden Lomberg Chemische Fabrik GmbH | Substituted quinolinone-alkanecarboxylic acids, their preparation, and medicaments containing them |
DE3063144D1 (en) * | 1979-09-07 | 1983-06-16 | Byk Gulden Lomberg Chem Fab | Substituted oxirane carboxylic acids, process for their preparation, their use and medicines containing them |
ES8202780A1 (es) * | 1979-10-31 | 1982-03-01 | Byk Gulden Lomberg Chem Fab | Procedimiento para la preparacion de acidos oxocarboxilicos sustituidos |
US4381301A (en) * | 1980-05-07 | 1983-04-26 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Substituted tricyclic thieno compounds, their synthesis, their use, their compositions and their medicaments |
US4337267A (en) * | 1980-08-25 | 1982-06-29 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenalkoxyalkyl- and phenoxyalkyl-substituted oxiranecarboxylic acids, their use and medicaments containing them |
US4430339A (en) * | 1980-08-29 | 1984-02-07 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | Substituted oxiranecarboxylic acids, their preparation and their use as medicaments |
EP0057428B1 (de) * | 1981-02-02 | 1985-04-10 | Byk Gulden Lomberg Chemische Fabrik GmbH | Tricyclische Pyrrole, Verfahren zu ihrer Herstellung, ihre Anwendung sowie sie enthaltende Arzneimittel |
US4578381A (en) * | 1982-07-05 | 1986-03-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
EP0187977B1 (en) * | 1984-12-18 | 1990-08-29 | Otsuka Pharmaceutical Co., Ltd. | Tetrahydroquinoline derivatives, process for preparing the same and anti-peptic ulcer compositions containg the same |
US5250527A (en) * | 1985-10-24 | 1993-10-05 | Smithkline & French Laboratories Limited | Pyridyl containing benzimidazoles, compositions and use |
GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
GB8717644D0 (en) * | 1987-07-24 | 1987-09-03 | Smithkline Beckman Intercredit | Compounds |
GB8804444D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804445D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804447D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804443D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804448D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804446D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
US5049567A (en) * | 1988-02-25 | 1991-09-17 | Smithkline Beckman Intercredit B.V. | Substituted 4-aminoquinazoline derivatives and method of use |
CA2011086A1 (en) * | 1989-03-17 | 1990-09-17 | Karl-Heinz Geiss | 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom |
GB8908229D0 (en) * | 1989-04-12 | 1989-05-24 | Smithkline Beckman Intercredit | Compounds |
GB8910722D0 (en) * | 1989-05-10 | 1989-06-28 | Smithkline Beckman Intercredit | Compounds |
DE3917233A1 (de) * | 1989-05-26 | 1990-11-29 | Basf Ag | 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel |
GB8918265D0 (en) * | 1989-08-10 | 1989-09-20 | Smithkline Beckman Intercredit | Compounds |
EP0480052B1 (en) * | 1990-03-28 | 1998-01-14 | Otsuka Pharmaceutical Co., Ltd. | Quinoline derivative, antiulcer drug containing the same, and production of said derivative |
EP0569396A1 (en) * | 1991-01-29 | 1993-11-18 | Smithkline Beecham Intercredit B.V. | Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion |
GB9126438D0 (en) * | 1991-12-12 | 1992-02-12 | Smithkline Beecham Intercredit | New quinoline derivatives |
-
1994
- 1994-05-11 IS IS4164A patent/IS4164A/is unknown
- 1994-05-12 TW TW083104301A patent/TW261613B/zh active
- 1994-05-19 IL IL10968594A patent/IL109685A/en not_active IP Right Cessation
- 1994-06-07 EG EG33594A patent/EG20435A/xx active
- 1994-06-08 SG SG1996004567A patent/SG47820A1/en unknown
- 1994-06-08 CN CN94192410A patent/CN1045955C/zh not_active Expired - Fee Related
- 1994-06-08 AT AT94919046T patent/ATE196134T1/de not_active IP Right Cessation
- 1994-06-08 CA CA002164875A patent/CA2164875A1/en not_active Abandoned
- 1994-06-08 JP JP50167595A patent/JP3623794B2/ja not_active Expired - Fee Related
- 1994-06-08 RU RU96100758A patent/RU2142454C1/ru active
- 1994-06-08 EP EP94919046A patent/EP0702672B1/en not_active Expired - Lifetime
- 1994-06-08 BR BR9406772A patent/BR9406772A/pt not_active Application Discontinuation
- 1994-06-08 WO PCT/SE1994/000552 patent/WO1994029274A1/en active IP Right Grant
- 1994-06-08 SK SK1549-95A patent/SK154995A3/sk unknown
- 1994-06-08 NZ NZ267740A patent/NZ267740A/en unknown
- 1994-06-08 HU HU9503529A patent/HUT75122A/hu unknown
- 1994-06-08 PL PL94311957A patent/PL177766B1/pl unknown
- 1994-06-08 CZ CZ953260A patent/CZ326095A3/cs unknown
- 1994-06-08 DE DE69425823T patent/DE69425823T2/de not_active Expired - Fee Related
- 1994-06-08 US US08/270,167 patent/US5889021A/en not_active Expired - Fee Related
- 1994-06-08 AU AU70121/94A patent/AU680516B2/en not_active Ceased
- 1994-06-08 ES ES94919046T patent/ES2150494T3/es not_active Expired - Lifetime
- 1994-11-23 EE EE9400424A patent/EE03123B1/xx unknown
-
1995
- 1995-12-05 NO NO954928A patent/NO305799B1/no not_active IP Right Cessation
- 1995-12-08 FI FI955896A patent/FI955896A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
EP0702672B1 (en) | 2000-09-06 |
IS4164A (is) | 1994-12-12 |
HU9503529D0 (en) | 1996-02-28 |
PL177766B1 (pl) | 2000-01-31 |
FI955896A0 (fi) | 1995-12-08 |
AU7012194A (en) | 1995-01-03 |
EG20435A (en) | 1999-04-29 |
BR9406772A (pt) | 1996-02-21 |
TW261613B (es) | 1995-11-01 |
SG47820A1 (en) | 1998-04-17 |
DE69425823D1 (de) | 2000-10-12 |
SK154995A3 (en) | 1996-09-04 |
NO954928L (no) | 1995-12-05 |
IL109685A0 (en) | 1994-11-28 |
WO1994029274A1 (en) | 1994-12-22 |
EP0702672A1 (en) | 1996-03-27 |
NO305799B1 (no) | 1999-07-26 |
DE69425823T2 (de) | 2001-01-18 |
CZ326095A3 (en) | 1996-05-15 |
CN1125438A (zh) | 1996-06-26 |
JPH09510951A (ja) | 1997-11-04 |
US5889021A (en) | 1999-03-30 |
NZ267740A (en) | 1997-05-26 |
AU680516B2 (en) | 1997-07-31 |
CA2164875A1 (en) | 1994-12-22 |
ES2150494T3 (es) | 2000-12-01 |
HUT75122A (en) | 1997-04-28 |
NO954928D0 (no) | 1995-12-05 |
EE03123B1 (et) | 1998-10-15 |
ATE196134T1 (de) | 2000-09-15 |
JP3623794B2 (ja) | 2005-02-23 |
FI955896A (fi) | 1995-12-08 |
RU2142454C1 (ru) | 1999-12-10 |
PL311957A1 (en) | 1996-03-18 |
CN1045955C (zh) | 1999-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3883383B2 (ja) | 胃酸分泌を阻害するイミダゾピリジン誘導体 | |
AP215A (en) | Substituted benzimidazoles, process for their preparation and their pharmaceutical use. | |
NO317304B1 (no) | Tetrahydropyridoetere | |
WO1995027714A1 (en) | Active compounds | |
US5889021A (en) | Active Compounds | |
JPS63502658A (ja) | 新規な物質の組成 | |
US5556863A (en) | Compound for gastric acid secretion inhibition | |
SK197A3 (en) | Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use | |
EP0302371B1 (en) | 7-(2-Methyl-4-aminopyrrolidinyl)naphthyridine and quinoline compounds | |
AU617181B2 (en) | Quinolonecarboxylic acids | |
EP0197318B1 (en) | Benzo[C]-1,5-naphthyridines, a process and intermediates for their preparation and their use as medicaments | |
LT3537B (en) | Quinoline derivatives | |
WO1991016311A1 (en) | 7-(substituted hydrazino)-4-oxoquinoline-3-carboxylic acid derivative, its salt and its ester | |
JPH01258680A (ja) | 4,8‐ジヒドロ‐8‐アリールイソキサゾロ〔4,3‐e〕〔1,4〕‐オキサゼピン‐5(6H)‐オン |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |